Company intelligence / Profile preview

Anya Biopharm

Taipei, Taipei, Taiwanus.anyahindmarch.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Anya Biopharm has demonstrated successful oral delivery of several therapeutic peptides in preclinical and clinical studies using its patented Mira/Je® technology. The company also markets or licenses several generic pharmaceutical products in Asia.

Therapeutic areas: OncologyMetabolic DisordersEndocrinologyImmunologyDermatologyCardiovascularNeurologyWomen's Health
Modalities: PeptidesSmall molecule
Industry: Biotech

Partnerships

Seeking collaborations with companies interested in enabling oral delivery of their drugs via Mira/Je®. No specific partners named publicly yet.

Beyond the preview

Go deeper on Anya Biopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anya Biopharm.

Explore the full profile